Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 1.00 |
| ▸ | DRD3 | P35462 | 9/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | DRD4 | P21917 | 6/20 | 0.63 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.61 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29547385 | 1.00 | DRD2 (1.00) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| SCHEMBL29429678 | 1.00 | DRD2 (1.00) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| SCHEMBL895742 | 1.00 | DRD2 (1.00) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| SCHEMBL895845 | 1.00 | DRD2 (1.00) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| Hydrochloric Acid SCHEMBL6824058 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| Hydrochloric Acid SCHEMBL31672141 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| Hydrochloric Acid SCHEMBL6824054 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| Hydrochloric Acid SCHEMBL3468007 | 0.98 | DRD2 (0.97) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| SCHEMBL9315535 | 0.90 | DRD2 (0.82) | DRD2DRD3ADRA1ADRD4CHRM2 | |
| SCHEMBL4210081 | 0.88 | DRD2 (0.79) | DRD2DRD3ADRA1ACHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023214011-A1 | ENZYMATIC METHOD FOR PREPARING (R)-3-AMINO-4-ARYL-BUTANOIC ACID DERIVATIVES | ENZYMICALS AG (DE) | 2023-11-09 | — | — | WO | claimed |
| EP-4273254-A1 | ENZYMATIC METHOD FOR PREPARING (R)-3-AMINO-4-ARYL-BUTANOIC ACID DERIVATIVES | Enzymicals AG (DE) | 2023-11-08 | — | — | EP | claimed |
| CN-113234057-B | Preparation method of rotigotine | 成都工业学院 | 2022-12-02 | — | — | CN | claimed |
| CN-113234057-A | Preparation method of rotigotine | 成都工业学院 | 2021-08-10 | — | — | CN | claimed |
| US-9879293-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | claimed |
| EP-2623593-B1 | NOVEL AMINOTRANSFERASE AND GENE ENCODING SAME, AND USE OF THE AMINOTRANSFERASE AND THE GENE | KANEKA CORP (JP) | 2017-07-12 | — | — | EP | claimed |
| EP-2022852-B1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE AMINE COMPOUND, RECOMBINANT VECTOR, AND TRANSFORMANT CARRYING THE VECTOR | KANEKA CORP (JP) | 2017-07-05 | — | — | EP | claimed |
| EP-2684953-B1 | MODIFIED AMINOTRANSFERASE, GENE THEREOF, AND METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUND USING SAME | KANEKA CORP (JP) | 2017-06-28 | — | — | EP | claimed |
| EP-2623595-B1 | NOVEL TRANSAMINASE SHOWING HIGH ACTIVITY FOR GLUTAMIC ACID, GENE ENCODING SAME, AND METHOD FOR UTILIZATION THEREOF | KANEKA CORP (JP) | 2016-11-02 | — | — | EP | claimed |
| US-9481870-B2 | Nucleic acid encoding a polypeptide having aminotransferase activity, vectors and host cells comprising the nucleic acid | KANEKA CORPORATION (JP) | 2016-11-01 | — | — | US | claimed |
| US-20090148899-A1 | METHOD FOR PRODUCING OPTICALLY-ACTIVE AMINE COMPOUND, RECOMBINANT VECTOR, AND TRANSFORMANT CONTAINING THE VECTOR | KANEKA CORPORATION (JP) | 2009-06-11 | — | — | US | claimed |
| EP-2022852-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE AMINE COMPOUND, RECOMBINANT VECTOR, AND TRANSFORMANT CARRYING THE VECTOR | Kaneka Corporation (JP) | 2009-02-11 | — | — | EP | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| EP-1889907-A1 | NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2008-02-20 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| EP-1278885-B1 | RESOLUTION OF AMINOTETRALINS | TORCAN CHEMICAL LTD (CA) | 2004-06-16 | — | — | EP | claimed |
| EP-1278885-A1 | RESOLUTION OF AMINOTETRALINS | TORCAN CHEMICAL Ltd (CA) | 2003-01-29 | — | — | EP | claimed |
| WO-2001083807-A1 | RESOLUTION OF AMINOTETRALINS | TORCAN CHEMICAL LTD. (CA) | 2001-11-08 | — | — | WO | claimed |
| US-6271005-B1 | BY STEREOSPECIFIC ACYLATION BY THE ENZYME PSEUDOMONAS CEPACIA LIPASE OF ONE STEREOISOMER WHILE LEAVING THE OTHER UNCHANGED; 5-METHOXY-2-AMINOTETRALIN CHEMICAL INTERMEDIATES TO A 2-AMINOTETRALIN-ETHYLTHIOPHENE PARKINSON'S DRUG | TORCAN CHEMICAL LIMITED (CA) | 2001-08-07 | — | — | US | claimed |